In vivo, 99mTc-FGF-2 showed high initial accumulation in the liver, spleen and lungs, followed by tumor localization with high Tumor/Muscle and Tumor/Blood ratios, particularly at 24 h post-injection. This evidence concerns the gene FGF2 and neoplasm.